CXCL12 and hepatocellular carcinoma: In addition, the study found that emodin exerts anti-HCC effects by targeting and down-regulating CXCR4, which is related to its inhibition of CXCL12-induced invasion and migration in HCC cell lines (Man et al., 2013).